1. Home
  2. BH vs FTRE Comparison

BH vs FTRE Comparison

Compare BH & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biglari Holdings Inc. Class B

BH

Biglari Holdings Inc. Class B

HOLD

Current Price

$386.32

Market Cap

1.5B

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$16.74

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BH
FTRE
Founded
1934
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BH
FTRE
Price
$386.32
$16.74
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$15.50
AVG Volume (30 Days)
70.8K
1.3M
Earning Date
11-07-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
7.91
N/A
Revenue
$386,507,000.00
$2,759,900,000.00
Revenue This Year
N/A
$3.21
Revenue Next Year
N/A
$0.25
P/E Ratio
$559.13
N/A
Revenue Growth
6.87
1.88
52 Week Low
$195.05
$3.97
52 Week High
$483.60
$18.67

Technical Indicators

Market Signals
Indicator
BH
FTRE
Relative Strength Index (RSI) 43.27 51.55
Support Level $365.35 $16.09
Resistance Level $408.87 $17.41
Average True Range (ATR) 25.86 1.09
MACD -11.75 -0.14
Stochastic Oscillator 8.71 43.38

Price Performance

Historical Comparison
BH
FTRE

About BH Biglari Holdings Inc. Class B

Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: